E-Prescribing Market

E-Prescribing Market Overview

The global e-prescribing market, valued at USD 3.43 billion in 2024, is estimated to grow to USD 4.51 billion in 2025 and USD 36.62 billion by 2035, representing a CAGR of 23.3% during the forecast period.

To learn more about this report, request a free sample copy

E-Prescribing is a form of technological prescription solution that allow physicians and medical practitioners to write medicinal prescriptions and send them to pharmacy / patient. Healthcare experts are shifting to digital solutions to streamline the administration task, diagnosis and treatment. However, medicinal prescriptions are still prescribed manually on faxed notes and handwritten notes, which creates a lot of errors. As per a research study published in 2024, prescribing errors accounted for 54% medication errors.  These manual prescription errors can cause potential damage to patient health and lead to severe consequences.

With e-Prescribing model, another research study predicted that there is a significant reduction in the medication errors and adverse drug events (99% and 98% relative risk reduction, respectively).  In order to reduce the risk of prescription errors, e-Prescribing solutions emerge as potential solutions for healthcare practitioners and pharmacies.

Notably, e-prescription software can automatically manage prescribed medications of patients and refill prescriptions based on the information collected through electronic medical record system. The automation of prescriptions helps to improve patient compliance with medications, reduces the errors chances and minimizes the paperwork required to write prescriptions. Considering the significances, a lot of industrial players are presently exploring advance e-prescribing software and technologies that can aid in automating the prescription work and enable healthcare practitioners to deliver quality care.

The strategic initiatives involve latest software launch, partnerships and acquisitions. For instance, in June 2024, Parachute Health (a leading platform for DME (Durable Medical Equipment) and HME (Home Medical Equipment) ordering) announced collaboration with two biggest healthcare companies and launched integrated healthcare solutions for revolutionizing DME e-Prescribing and prior authorization to reduce cost for health plans, clinicians and DME providers. With this newly launched platform functionality, Parachute Health is aiming to streamline prior authorization process for improving patient outcomes and facilitating point-of-care.  

Owing to the ongoing penetration of industrial players for the development of integrated e-Prescribing solutions, we believe that the e-prescribing market will remain competitive, offering lucrative opportunities for driving innovation during the forecast period.

E-Prescribing Market Segmentation Insights

The market report provides comprehensive details on the leading industry players who are currently active across different segments of the e-prescribing industry.

E-Prescribing Market: Report Attributes / Market Segmentation

One of the key objectives of the e-prescribing market report was to estimate the current market size, opportunity and the market growth potential, over the forecast period, till 2035.

Key Report Attributes	Details
Historical Trend	Since 2019
Forecast Period	Till 2035
Current Market Size	USD 4.51 billion
Market Size 2035	USD 36.62 billion
Market CAGR	~23.3%
Type of Product	Solutions (Integrated Solutions, and Standalone Solutions) Services (Implementation, Training and Network)
Type of Deployment	On-Premise Solutions Web-Based / Cloud Based Solutions
Type of Component	Hardware Software Services
Type of Usage Method	Handheld Devices Computer-Based Devices
Type of Substance	Controlled Substances Non-Controlled Substances
Type of System	Integrated e-Prescribing Systems Standalone e-Prescribing Systems
Type of Specialty	Oncology Sports Medicine Neurology Cardiology Other Specialties
End User	Hospitals Office-Based Physicians Pharmacies
Geographical Regions	North America (US, Canada, Mexico) Europe (France, Germany, Italy, Spain, UK, Rest of Europe) Asia Pacific (China, India, Japan and Rest of Asia Pacific) Middle East and North Africa (Egypt, Saudi Arabia and UAE) Latin America (Argentina and Brazil)
Key Companies Profiled	Athenahealth Cerner (Oracle) Change Healthcare DrFirst eClinicalWorks Epic Systems Henry Schein McKesson NXGN Management Networking Technology  (RXNT) Practice Fusion Parachute Health RelayHealth Surescripts Veradigm (AllScripts Healthcare) (A full list of key companies captured is available in the report)
PowerPoint Presentation (Complimentary)	Available
Customization Scope	15% Free Customization
Excel Data Packs (Complimentary)	Available

We have provided informed estimates on the likely evolution of the market for the forecast period. Additionally, the market report features the likely distribution of the current and forecasted opportunity within the market distributed across various segments such as type of product (solutions (integrated solutions, and standalone solutions) and services (implementation, training and network)), type of deployment (on-premise solutions, and web-based / cloud based solutions), type of component (hardware, software and services), type of usage method (handheld devices and computer-based devices), type of substance (controlled substances and non-controlled substances), type of system (integrated e-prescribing systems and standalone e-prescribing systems), type of specialty (oncology, sports medicine, neurology, cardiology and other specialties), end user (hospitals, office-based physicians and pharmacies), geographical regions (North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America), and leading players.

To account for the uncertainties associated with the development of e-prescribing solutions and to add robustness to our model, we have provided three market forecast scenarios, portraying the conservative, base and optimistic tracks of the market’s evolution.

All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this market research report are in USD, unless otherwise specified.

E-Prescribing Market Share Insights

Market Share by Type of Product

Based on the type of product, the global market is segmented into solutions (integrated solutions, and standalone solutions) and services (implementation, training and network). According to our e-prescribing market analysis, solutions hold the highest current market share. This can be attributed to the growing preferences for software solutions to manage regular prescriptions of patients. Solutions, such as integrated solutions and standalone solutions have been integrated in healthcare industry to address the unmet operational requirements (specifically prescription based).

It is important to highlight here that with growing demand for software and technologies, we believe that service segment is likely to register a higher CAGR during the forecast period. Services based e-Prescribing platforms and services are incredibly useful for pharmacies to send and receive electronic prescriptions from healthcare practitioners. Moreover, services are cost-effective and easily implemented to run e-prescribing, which further becomes a solid reason for highest growth rate.

Market Share by Type of Deployment

This segment highlights the distribution of global market based on type of deployment into on-premise solutions, and web-based / cloud based solutions. Among these, web-based / cloud based solutions accounts for the largest e-prescribing market share (nearly 60%) and this segment is likely to remain dominant during the forecast period. Web-based / cloud-based solutions are cost-effective and quickly integrate with existing healthcare systems. Moreover, cloud-based solutions are widely adopted by small pharmacies, physicians and healthcare providers, which is anticipated to be a key growth driver of this segment.

Additionally, cloud-based solutions enable prescribing of medicine from any place at any given time, which further enhance its accessibility specifically in remote areas. Driven by the ongoing demand, this segment will continue to grow at a steady pace during the forecast period.

Market Share by Type of Component

The global e-prescribing market is categorized across different types of components, such as hardware, software and services. According to our projection, currently software occupies the highest share of the market. e-Prescribing software can easily integrate with electronic health records to facilitate the prescription of medicine effortlessly. Moreover, the software give access to drug database in real time and offer better interoperability, which further contributed to the higher adoption rate of software. However, in the long run, services segment accounts for the highest CAGR during the forecast period. This can be attributed to the growing shift towards services provider for consulting, training, implementation and ongoing support.

Market Share by Type of Usage Method

Based on the type of usage method, the global e-prescribing market is distributed across handheld devices and computer-based devices. According to our projection, currently handheld devices account for the highest share of the market. Notably, handheld services such as smartphones, tablets, computers and PDAs are widely utilized by the patients and healthcare providers for medicine prescribing. Moreover, handheld devices allow prescribers to access patient medication history and other medical information to make a precise decision.

However, it is worth mentioning here that computer-based devices may growth at a substantial CAGR in the future. This can be attributed to the fact that computer based e-Prescribing is broadly used in hospitals to securely transmit prescription data to the pharmacies with a secure transmission network. Further, computer-based e-Prescribing enables storage and transmission of vast amount of data in hospitals, which further contributed to the lucrative growth potential of this segment during the forecast period.

Market Share by Type of Substance

The global market is further bifurcated based on the type of substance into controlled substances and non-controlled substances. According to our e-prescribing market forecast, currently, the controlled substance hold the highest share of the market. This can be attributed to the growing demand for e-Prescribing software and technologies by physicians for prescribing controlled substances. Further, the e-prescribing software helps to reduce the errors in prescribing, prescription irregularities and frauds in medicinal prescribing, thereby enhance workflow efficiency in clinics.

However, the non-controlled substances segment is likely to grow at a higher CAGR during the forecast period. This is primarily due to the fact that e-Prescribing technology helps to transmit prescriptions / non controlled substances to patients directly for managing disease conditions, such as diabetes and hypertension. Moreover, non-controlled drugs are available broadly to local pharmacies and online pharmacies so patients can directly access through e-Prescribing solutions, which further increase its adoption rate.

Market Share by Type of System

On the basis of type of system, the global e-Prescribing market is segmented into integrated e-prescribing systems and standalone e-prescribing systems. Amongst these, standalone e-prescribing systems segment accounts for the highest share of the market. This can be attributed to the fact that standalone e-prescribing is an independent system which is cost-effective and user-friendly. The system has been widely adopted by the patients for receiving medical prescribing remotely for managing disease conditions. Moreover, it can easily integrate with existing systems to facilitate digital prescriptions. Driven by the increasing adoption, this segment will continue to gain traction and is poised to grow at a higher CAGR during the forecast period.

Market Share by Type of Specialty

Based on the type of specialty, the global e-prescribing market is categorized into oncology, sports medicine, neurology, cardiology and other specialties. According to our projection, currently sport medicine accounts for the highest share (more than 20%) of the market. This is due to the rising adoption of telehealth services, telemedicine and remote patient monitoring solutions by sports person. Telemedicine ensure real-time services and sport persons can directly connect with healthcare providers for prescriptions during emergencies. Moreover, athletes / sport persons require routine medication consultation for treating injuries which further increases its demand by sports persons.

However, in the long run, we believe that the cardiology segment is projected to grow at the fastest CAGR during the forecast period. With rising incidence of cardiovascular diseases across the globe, there has been a surge in the demand for e-Prescribing systems for quick scheduling, medica prescription orders and streamlining patients and providers coordination.

Market Share by End User

The global e-prescribing market is further segmented into end users, such as hospitals, office-based physicians and pharmacies. According to our projection, currently hospitals account for the largest share (35%) of the market. This can be attributed to the widespread adoption of digital health solutions for offering remote consultation and medical prescription. Moreover, e-Prescribing solutions offer quick analysis to patient health information and history to understand condition, patient allergies and treatment, which further enhance safety during medicine prescriptions.

Furthermore, hospitals are continually embracing the latest technologies to enhance patient outcomes which has underscored the demand for e-Prescribing for delivering right prescription. However, in the long run, we believe pharmacies segment is likely to grow at a higher CAGR during the forecast period. Pharmacies are integrating digital health solutions, such as e-Prescribing to reduce medication errors during medication prescriptions.

Market Share by Geographical Region

Based on the geographical region, the global e-prescribing market is distributed across North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America. According to our study, North America is currently dominating with a market share of 45% and is poised to remain dominant during the forecast period. This can be attributed to the growing adoption of smart healthcare technologies for medical consultations and prescriptions. Furthermore, the increasing advancements in the healthcare infrastructure and penetration of telemedicine have further contributed to the highest share of this segment during the forecast period.

Notably, Europe also occupied a significant e-prescribing market size driven by stringent guidelines by the EMA for reducing medical prescribing errors. Moreover, the European healthcare sector is increasingly e-Prescribing software solutions to enhance patient compliance with treatments which is anticipated to be a significant reason for substantial share.

However, in Asia-Pacific, the market for e-Prescribing is expected to register a higher CAGR during the forecast period. This is primarily due to the rising technological innovations and adoption of digital health solutions in Asian countries to manage chronic conditions.

E-Prescribing Market Dynamics Insights

The “E-Prescribing Market: Industry Trends and Global Forecasts, till 2035” market report features an extensive study of the current market landscape, market size, market share, market growth, market trends, market value, market forecast, market outlook, statistics and future opportunities for stakeholders in the e-prescribing industry. The market research report lays emphasis on the novel industrial players who are presently focusing on the development of advanced e-Prescribing solutions.

E-Prescribing Market Competitive Landscape

Currently, the global e-prescribing market is witnessing a wide array of established and new entrants who are presenting aiming for technological innovations. The primary aim of the industrial players is to enhance product portfolio, technological innovations and services expansion. For instance, in March 2024, Positive Solutions become the latest pharmacy system supplier for the development and testing technology to deliver an EPS (Electronic Prescription Service) in Wales. It is important to highlight here that in July 2024, Positive Solutions become the leading health tech provider having its e-Prescribing software to be approved for community pharmacies in Wales. The EPS utilize general practitioners and other prescribers for sending prescriptions electronically to the pharmacies.  ,   Similarly, players such as Athenahealth, eClinical Works and Allscripts are leveraging competitive edge in the market, which is anticipated to drive market at a steady pace during the forecast period. Overall, the market will remain competitive featuring the presence of several small, mid-sized and large industrial players.

Market Drivers: Increasing Acceptance of Digital Healthcare Solutions and Electronic Prescriptions

Notably, the penetration of digital healthcare solutions and telehealth services has contributed to the growth of eprescription software. The integration of e-prescribing solutions allows medical practitioners to prescribe medicine to pharmacy and patients hassle-free without relying on paperwork. Moreover, electronic prescription solutions reduce errors during writing medicine and automatically initiate refilling of prescription, which enhance patient compliance. Driven by the benefits offered, e-prescribing solution and services has been adopted on a large scale, which has become a primitive driver of the market. Additionally, the supportive healthcare IT infrastructure and government support for the adoption of e-Prescribing model has further enhanced the adoption rate of these software solutions.

Market Challenges: High Initial Investments and Data Privacy

e-Prescribing software and solutions has been adopted on a large scale driven by ease of medicinal prescription and shift towards digital technologies. However, there are several challenges that may limit the adoption of the e-Prescribing on a large scale. One of the significant challenges is high initial investment associated with the installation of e-Prescribing solutions. Further, the cost associated with hardware system, software and maintenance of these systems may limit the adoption of e-Prescribing solutions. Moreover, concerns associated with data privacy may also impact on the market growth of e-Prescribing solutions and services.

E-Prescribing Market Trends: Penetration of Telehealth Services and Digital Solutions for Ordering Prescriptions Remotely

Some of the groundbreaking trends that are anticipated to propel the market includes penetration of telehealth services and digital solutions demand for ordering prescription remotely. Additionally, the rising adoption of automated solutions and electronic health records for medication prescription and management has further contributed to lucrative growth of this market. It is important to highlight here that healthcare practitioners are looking for user-friendly e-Prescribing solutions that helps in prescribing medicines to patients and pharmacy, which is further anticipated to be a key growth factor of the market.

E-Prescribing Market Size Analysis

Currently, the global e-prescribing market is expected to be valued at USD 4.51 billion and is projected to reach USD 36.62 billion by 2035. Driven by the widespread adoption of e-prescribing software for medicine prescription and management, the market is expected to grow at a CAGR of 23.3% during the forecast period. Notably, the market has further been bolstered by the increasing partnerships between industrial players to develop the latest e-prescribing platforms and services. For instance, in October 2024, Parachute Health partnership with Athenahealth to join Athenahealth® Marketplace Program. This newly launched application will be available to simplify DME e-Prescribing at point of care.  

Similarly, several industrial players are entering into the marketplace for product portfolio enhancement and strategic initiatives, which is anticipated to maintain competitiveness in this industry over a long term.

Leading Companies in e-Prescribing Market

Examples of key companies active in e-prescribing industry (which have also been profiled in this market report; the complete list of companies is available in the full report) include Athenahealth, Cerner (Oracle), Change Healthcare, DrFirst, eClinicalWorks, Epic Systems, Henry Schein, McKesson , NXGN Management, Networking Technology  (RXNT), Practice Fusion, Parachute Health, RelayHealth, Surescripts and Veradigm (Allscripts Healthcare). This market report includes an easily searchable excel database of all the companies providing e-prescribing solutions and services.

E-Prescribing Market Report Coverage

The market report presents an in-depth analysis, highlighting the capabilities of various companies engaged in this domain across different segments. Amongst other elements, the market report includes:

• A preface providing an introduction to the full report, E-Prescribing market, 2019-2025 (Historical Trends), and Future Forecast till 2035 (Forecasted Estimates).
• An outline of the systematic research methodology adopted to conduct the study on the e-prescribing industry, providing insights on the various assumptions, methodologies, and quality control measures employed to ensure the accuracy and reliability of our findings.
• An overview of economic factors that impact the overall market, including historical trends, currency fluctuation, foreign exchange impact, recession, and inflation measurement.
• An executive summary of the insights captured during our research. It offers a high-level view of the current state of the e-prescribing market and its evolution in the mid-and long-term.
• A detailed assessment of the market landscape is based on several relevant parameters, including years of experience, company size, headquarters location, and ownership structure.
• Elaborated profiles of prominent players engaged in offering e-prescribing software, featuring information on their year of establishment, location of headquarters, company size, company mission, company footprint, management team, contact details, financial information, operating business segments, e-prescribing portfolio, recent developments, and an informed future outlook.
• A discussion on affiliated trends, key drivers, and challenges under a SWOT framework, which is likely to impact the industry's evolution, along with a Harvey ball analysis, highlighting the relative effect of each SWOT parameter on the overall e-prescribing industry.
• A market impact analysis features a discussion on the factors that can impact the e-prescribing market growth.
• A detailed estimate of the current market size and the future growth potential of the market over the next decade. Based on multiple parameters, we have provided an informed estimate of the market's evolution during the forecast period till 2035. The report also features the likely distribution of the current and forecasted opportunities within the e-prescribing industry. Further, in order to account for future uncertainties and to add robustness to our model, we have provided three forecast scenarios, namely conservative, base, and optimistic scenarios, representing different tracks of the industry’s growth.
• Detailed projections of the current and future e-prescribing market across various types of products, including solutions (integrated solutions, and standalone solutions) and services (implementation, training and network).
• Detailed projections of the current and future market for e-prescription across various types of deployment, including on-premise solutions, and web-based / cloud based solutions.
• Detailed projections of the current and future revenues generated by e-prescribing stakeholders across various types of component, including hardware, software and services.
• Detailed projections of the current and future e-prescribing market across various types of usage method, including handheld devices and computer-based devices.
• Detailed projections of the current and future e-prescribing industry across various types of substance, including controlled substances and non-controlled substances.
• Detailed projections of the current and future revenues generated by e-prescribing stakeholders across various types of system, including integrated e-prescribing systems and standalone e-prescribing systems.
• Detailed projections of the current and future e-prescribing market across various types of specialty, including oncology, sports medicine, neurology, cardiology and other specialties.
• Detailed projections of the current and future market for e-prescribing across various types of end user, including hospitals, office-based physicians and pharmacies.
• Detailed projections of the current and future market for e-prescribing industry across various key geographical regions, such as North America (US, Canada and Mexico), Europe (France, Germany, Italy, Spain, UK and Rest of the Europe), Asia-Pacific (China, India, Japan and Rest of Asia-Pacific), Middle East and North Africa (Egypt, Saudi Arabia and UAE) and Latin America (Argentina and Brazil).

Recent Developments in e-Prescribing Market

Several recent developments have taken place in the field of e-prescribing. We have outlined some of these recent initiatives below.

• In October 2024, athenahealth launched Ambient Notes, a novel solution designed to reduce the clinical note documentation burden, through the integration of generative AI technology and ambient listening into athenaOne experience.
• In the same month, Parachute Health revealed the launch of power AI Intake solution that empower clinicians with simple DME / HME ordering to improve patient care.
• In June 2024, Edgepark announced the launch of ostomy storefront through Parachute Health. This storefront is launched to receive digital prescription orders directly from healthcare providers for patients.
• In March 2024, Change Healthcare set up an advanced electronic prescription services that helps to get some relief to the physicians and pharmacies that had faced fallout from cyberattack.